Drug Type siRNA |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization EnhancedBio, Inc.Startup |
Active Organization EnhancedBio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | KR | EnhancedBio, Inc.Startup | 16 Sep 2022 |
Pancreatic Carcinoma | Preclinical | KR | EnhancedBio, Inc.Startup | 16 Sep 2022 |